Register for ALS Clinical Trials Unboxed

On Wednesday, August 26, 2026 at 1 p.m. ET, join ALS Canada for our next ALS Clinical Trials Unboxed webinar to learn more about ongoing ALS clinical trials.

In this webinar, Trace Neuroscience will provide an overview of TRCN-1023, an investigational treatment being studied for ALS, and the upcoming FUNCTION ALS Phase 1/2 clinical trial.

Speakers will explain how TRCN-1023 is designed to work, what the trial will study, and what it may mean for people living with ALS and their families as trial sites open in Canada.

Speakers:

Dr. Eric Green, CEO of Trace Neuroscience
Dr. Irina Antonijevic, CMO of Trace Neuroscience
Megan Baierlein, COO of Trace Neuroscience

First Name

Last Name

Email Address

City

Province

Would you please share how you are connected to the ALS community?

Please submit your questions (optional)

I give permission for the ALS Society of Canada to email me about its activities and how I can support its work toward a world free of ALS.

Yes, I want to subscribe

No, unsubscribe me

Please note that ALS Canada does not provide medical advice or make referrals related to drug therapies or alternative therapies. These questions should be discussed directly with a medical professional – ideally an ALS neurologist, who would be qualified to interpret clinical information for individual situations.

Please visit our list of ALS clinics to help you to connect with a clinic in your area.